The Global Brain Cancer Diagnostics Market presents opportunities in AI-driven precision diagnostics and non-invasive liquid ...

FRIDAY, Jan. 23, 2026 (HealthDay News) — Brain tumors are abnormal growths of cells in or around the brain. They can be ...

Rising traumatic brain injury cases, the development of AI-enabled monitoring systems, and the increasing infrastructure of critical care facilities are contributing to the growth of the global ICP ...

Scientists in Scotland have shown that a type of laser already similar to the one currently used in routine eye surgery could ...

Researchers analyzed the diagnostic value of stereotactic brain biopsy in patients with leukemia presenting central ...

Expanded eligibility for advanced ischemic stroke therapies and the first detailed recommendations pediatric stroke care are ...

Financial Guidance As of September 30, 2025, cash, cash equivalents and investments totaled $413.0 million, which the company expects will be sufficient to fund its operating plan into 2H 2028, beyond ...

RevBio, Inc., announced that it has received investigational device exemption (IDE) approval from the FDA to conduct a multi-center randomized controlled pivotal clinical trial to use TETRANITE (R) to ...

Central retinal artery occlusion can result in permanent vision loss. Effective treatment is lacking. We conducted a phase 3, double-blind, double-dummy, randomized, controlled trial involving ...

Baystreet.ca News Commentary – The global oncology market is charging toward a massive $668 billion valuation by 2034[1], ...

Think your daily vitamin routine is harmless? A leading neurologist warns that "stacking" popular over-the-counter pills ...